Synonym/Acronym
monospot, Epstein-Barr test, heterophil antibody test, IM serology.
Rationale
To assess for Epstein-Barr virus (EBV) and assist with diagnosis of infectious mononucleosis.
Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Normal Findings
(Method: Infectious mononucleosis antibodies (rapid IM) test by agglutination; serological tests for EBV early antigen D (IgG antibody), EBV nuclear antigen (IgG antibody), EBV viral capsid antigen (IgG antibody), EBV viral capsid antigen (IgM antibody) by immunoassay).
Rapid IM | Negative (indicating nondetectable levels of the infectious mononucleosis heterophile antibody) | |
EBV antibody to early antigen D (IgG antibody) | 10.9 Units/mL or less (EBV antibody to early antigen D, IgG antibody not detected) | |
EBV antibody to nuclear antigen (IgG antibody) | 21.9 Units/mL or less (EBV antibody to nuclear antigen IgG not detected) | |
EBV antibody to viral capsid antigen (IgG antibody) | 21.9 Units/mL or less (EBV antibody to viral capsid antigen IgG not detected) | |
EBV antibody to viral capsid antigen (IgM antibody) | 43.9 Units/mL or less (EBV antibody to viral capsid antigen IgM not detected) |
(Study type: Blood collected in a gold-, red-, or red/gray-top tube; related body system: ) .
Infectious mononucleosis is caused by the human herpesvirus 4, more commonly known as the Epstein-Barr virus. The incubation period is 10 to 50 days, and the symptoms last 1 to 4 wk after the infection has fully developed. The hallmark of EBV infection is the presence of heterophilic (cross-reacting) antibodies, also called Paul-Bunnell-Davidsohn antibodies, which are immunoglobulin M (IgM) antibodies that agglutinate sheep or horse red blood cells. The disease induces formation of abnormal lymphocytes in the lymph nodes; stimulates increased formation of heterophil antibodies; and is characterized by fever, cervical lymphadenopathy, tonsillopharyngitis, and hepatosplenomegaly.
EBV is also thought to play a role in Burkitt lymphoma, nasopharyngeal cancer, and chronic fatigue syndrome. If the results of the heterophil antibody screening test are negative and infectious mononucleosis is highly suspected, EBV-specific serology should be requested (EBV early antigen D antibody IgG, EBV nuclear antigen antibody IgG, EBV viral capsid antigen antibody IgG, EBV viral capsid antigen antibody IgM). Molecular testing methods (e.g., polymerase chain reaction) are available to identify the presence of EBV viral DNA and to monitor viral load in patients being treated for other EBV-related diseases.
Before the Study: Planning and Implementation
Teaching the Patient What to Expect
After the Study: Implementation & Evaluation Potential Nursing Actions
Treatment Considerations
Fatigue
Infection
Clinical Judgement
Follow-Up Evaluation and Desired Outcomes